1Zignego AL, Gragnani L, Piluso A, et al.Virus-drivcn autoimmunity and lymphoproliferation: the example of HCV infection[J]. Expert Rcv Clin Immunol, 2015, 11(1): 15-31. DOI: 10.1586/1744666X.2015.997214.
2Dalia S, Chavez J, Castillo JJ, et al. Hepatitis B infection increases the risk ofnon-Hodgldn lymphoma: a meta-analysis of observational studies[J]. Leuk Res, 2013, 37(9): 1107-1115. DOI: 10.1016/ j .leukres .2013.06.007.
3Cacoub P, Gragnani L, Comarmond C, et al. Extrahepatic manifestations of chronic hepatitis C virus infaction[J]. Dig Liver Dis, 2014, 46 Suppl 5: S165-173. DOI: 10.1016/j.dld.2014.10.005.
4Dai B, Chen AY, Corkum CP, et al. Hepatitis C virus upregulates B-ceU receptor signaling: a novel mechanism for HCV-assoeiated B-cell lymphoproliferative disorders[J].Oncogene, 2016, 35(23): 2979-2990. DOI: 10.1038/onc.2015.364.
5Augello C, Gianelli U, Savi F, et al. MicroRNA as potential biomarker in HCV-associated diffuse large B-cell lymphoma[J]. J Clin Pathol, 2014, 67(8): 697-701. DOI: 10.1136/jclinpath-2014-202352.
6Deng L, Song Y, Young KH, et al. Hepatitis B vires-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin[J]. Oncotarget, 2015, 6(28): 25061-25073. DOI: 10.18632/oncotarget.4677.
